Nihon Kohden SVM-7200 Series Vital Signs Monitor

K190468 · Nihon Kohden Corporation · MWI · May 28, 2019 · Cardiovascular

Device Facts

Record IDK190468
Device NameNihon Kohden SVM-7200 Series Vital Signs Monitor
ApplicantNihon Kohden Corporation
Product CodeMWI · Cardiovascular
Decision DateMay 28, 2019
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.2300
Device ClassClass 2
AttributesPediatric, 3rd-Party Reviewed

Intended Use

The SVM-7200 series Vital Signs Monitor is intended for monitoring and alarming of physiologic parameters, including non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, non-invasive functional oxygen saturation of arteriolar hemoglobin (SpO2), and temperature, on adult, pediatric, and neonatal patients in hospital environments when used by clinical physicians or appropriate medical staff under the direction of physicians.

Device Story

SVM-7200 series Vital Signs Monitor; 8-inch TFT color display; spot check and continuous monitoring modes. Inputs: NIBP (oscillometric), SpO2 (Masimo, Nellcor, or Nihon Kohden probes), and temperature (Covidien FILAC 3000 or Exergen TAT-5000S). Outputs: real-time physiologic data and alarms (visual/audible). Used in hospitals, clinics, surgery centers, and wards by clinicians/nurses. Wired or wireless LAN connectivity. Device provides continuous monitoring and alarming to assist clinical decision-making; benefits include patient status tracking and timely intervention for abnormal vitals.

Clinical Evidence

Bench testing only. No new clinical accuracy validation was performed; the device leverages previously cleared clinical accuracy data for its integrated subsystems (Masimo, Nellcor, Nihon Kohden, Covidien, Exergen). Performance testing included software verification/validation (unit, integration, system level), summative usability validation in a simulated environment, and electrical/EMC safety testing per IEC 60601-1, 60601-1-2, 60601-1-8, 60601-2-49, 80601-2-30, ISO 80601-2-56, and ISO 80601-2-61.

Technological Characteristics

8-inch TFT color display; Lithium-Ion battery; 100-240V AC power. Parameters: NIBP (oscillometric), SpO2 (Masimo/Nellcor/Nihon Kohden), Temperature (Covidien/Exergen). Connectivity: Wired/Wireless LAN. Standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-8, IEC 60601-2-49, IEC 80601-2-30, ISO 80601-2-56, ISO 80601-2-61, IEC 62304, AAMI TIR69, IEEE C63.27. Software lifecycle per IEC 62304.

Indications for Use

Indicated for monitoring and alarming of physiologic parameters (NIBP, pulse rate, SpO2, temperature) in adult, pediatric, and neonatal patients in hospital environments.

Regulatory Classification

Identification

A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath. May 28, 2019 Nihon Kohden Corporation % Dave Yungvirt CEO Third Party Review Group, LLC 25 Independence Blvd Warren, New Jersey 07059 Re: K190468 Trade/Device Name: Nihon Kohden SVM-7200 series Vital Signs Monitor Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer and Rate Alarm) Regulatory Class: Class II Product Code: MWI, DXN, DQA, FLL Dated: April 25, 2019 Received: April 26, 2019 Dear Dave Yungvirt: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, for Matthew Hillebrenner Director (Acting) Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K190468 #### Device Name Nihon Kohden SVM-7200 series Vital Signs Monitor #### Indications for Use (Describe) The SVM-7200 series Vital Signs Monitor is intended for monitoring of physiologic parameters, including non-invasive blood pressure (systolic, and mean arterial pressure), pulse rate, non-invasive functional oxygen saturation of arteriolar hemoglobin (SpO2), and temperature, and neonatal patients in hospital environments when used by clinical physicians or appropriate medical staff under the direction of physicians. | Type of Use (Select one or both, as applicable) | | |-----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------| | <div style="display:flex; align-items:center;"><span> X</span>Prescription Use (Part 21 CFR 801 Subpart D)</div> | <div style="display:flex; align-items:center;"><span> </span>Over-The-Counter Use (21 CFR 801 Subpart C)</div> | ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/1 description: The image contains the logo for NIHON KOHDEN. The logo consists of a blue square with a white abstract design on the left, followed by the company name "NIHON KOHDEN" in blue, sans-serif font. The text is bold and slightly blurred, giving it a soft appearance. # 510(k) Summary K190468 | Sponsor: | Nihon Kohden Corporation<br>1-31-4 Nishiochiai, Shinjuku-Ku<br>Tokyo, Japan 161-8560 | |----------|--------------------------------------------------------------------------------------| | Contact: | Natalie J. Kennel<br>NJK & Associates | | Address | 13721 Via Tres Vista<br>San Diego, CA 92129 | | Phone | (858) 705-0350 | | Fax | (858) 764-9739 | | email | nkennel@njkconsulting.com | - May 22, 2019 Date Prepared: # DEVICE INFORMATION: | Proprietary Name: | Nihon Kohden SVM-7200 series Vital Signs Monitor | | |-------------------|------------------------------------------------------------------------------------|--| | Common Name: | Vital Signs Monitor, Patient Monitor | | | Classification: | Monitor, Physiological, Patient, (without arrhythmia detection or alarms) Class II | | | Product Codes: | MWI, DXN, DQA, FLL | | | Regulations: | 21 CFR 870.2300 | | | Predicate: | Capsule Technologies SmartLinx Vitals Plus Patient Monitoring System (K171751) | | {4}------------------------------------------------ Reference Device: Nihon Kohden Bedside Monitor, BSM-6000 series (K080342) {5}------------------------------------------------ ## PRODUCT DESCRIPTION: The SVM-7200 series Vital Signs Monitor is intended to be used by clinicians, doctors, nurses, and medically qualified personnel for measuring noninvasive blood pressure (NIBP), noninvasive functional oxygen saturation of arteriolar hemoglobin (SpO2), body temperature (TEMP) of one patient at a time. The monitors can be used in the specialized health care environment such as hospitals, clinics, special medical facilities, independent surgery centers, multitherapy facilities and wards. Adults, children and neonates can be monitored using this device. The SVM-7200 series monitors have an eight-inch TFT color display and two modes: spot check and continuous mode. The monitor can operate with either a wired or wireless LAN connection. The models included are: | Model Name | Screen Size<br>(inch) | Parameters | |------------|-----------------------|--------------------------------------| | SVM-7230 | 8 | Masimo SpO2, NIBP, Temperature | | SVM-7250 | 8 | Nellcor SpO2, NIBP, Temperature | | SVM-7260 | 8 | Nihon Kohden SpO2, NIBP, Temperature | The thermometer options include the commercially available Covidien FILAC 3000 Thermometer or Exergen TAT-5000S Temporal Scanner. ### INDICATIONS FOR USE: The SVM-7200 series Vital Signs Monitor is intended for monitoring and alarming of physiologic parameters, including non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, non-invasive functional oxygen saturation of arteriolar hemoglobin (SpO2), and temperature, on adult, pediatric, and neonatal patients in hospital environments when used by clinical physicians or appropriate medical staff under the direction of physicians. ### TECHNOLOGICAL CHARACTERISTICS - SUBSTANTIAL EQUIVALENCE: Table 1 is a detailed comparison of the Nihon Kohden SVM-7200 Series Vital Signs Monitor and its predicate, SmartLinx Vitals Plus. The Nihon Kohden SVM-7200 Vital Signs Monitor is substantially equivalent to the SmartLinx Vitals Plus Patient Monitoring System, other than the minor differences described below. These differences do not raise questions regarding safety or efficacy. {6}------------------------------------------------ | | SmartLinx Vitals Plus | SVM-7200 Series Vital Signs Monitor | |----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Characteristic | Predicate Device (K171751) | Subject Device | | Indications for<br>Use | The SmartLinx Vitals Plus Patient<br>Monitoring System is intended for<br>monitoring and alarming of physiologic<br>parameters, including non-invasive blood<br>pressure (systolic, diastolic, and mean<br>arterial pressure), pulse rate, functional<br>arterial oxygen saturation (SpO2), and<br>temperature, on adult, pediatric, and<br>neonatal patients in hospital environments<br>when used by clinical physicians or<br>appropriate medical staff under the<br>direction of physicians. | The SVM-7200 series is intended for monitoring<br>and alarming of physiologic parameters,<br>including non-invasive blood pressure (systolic,<br>diastolic, and mean arterial pressure), pulse rate,<br>non-invasive functional oxygen saturation of<br>arteriolar hemoglobin (SpO2), and temperature,<br>on adult, pediatric, and neonatal patients in<br>hospital environments when used by clinical<br>physicians or appropriate medical staff under the<br>direction of physicians. | | NIBP<br>Measurement | Oscillometric design for Spot Check and<br>Intervals Mode measurements. | Oscillometric design for Spot Check and<br>Intervals Mode measurements. | | SpO2 Monitoring | Masimo SpO2 for Spot Check<br>measurements and Continuous<br>Monitoring with the following features:<br>1) Pulse tone pitch varying with oxygen<br>saturation<br>2) SpO2 alarm delay<br>3) SpO2 sensor off alarm | Masimo SpO2, Nellcor SpO2, or Nihon Kohden<br>SpO2 for Spot Check measurements and<br>Continuous Monitoring with the following<br>features:<br>1) Pulse tone pitch varying with oxygen<br>saturation<br>2) SpO2 alarm delay<br>3) SpO2 sensor off alarm | | Temperature<br>Measurement | Two different thermometry options:<br>1) Covidien FILAC 3000 thermometer<br>2) Exergen TAT- 5000S temporal scanner | Two different thermometry options:<br>1) Covidien FILAC 3000 thermometer<br>2) Exergen TAT- 5000S temporal scanner | | Alarms | Configuration, annunciation, and<br>acknowledgement of physiological and<br>technical alarms for (Sys, Dia, MAP,<br>Pulse Rate, SpO2, and Temp).<br>Alarms are visibly annunciated and<br>acknowledged on the screen.<br>Alarms are audibly annunciated via<br>speaker. | Configuration, annunciation, and<br>acknowledgement of physiological and technical<br>alarms for (Sys, Dia, MAP, Pulse Rate, SpO2,<br>and Temp).<br>Alarms are visibly annunciated and<br>acknowledged on the screen.<br>Alarms are audibly annunciated via speaker. | | Energy Source | Battery type: Lithium-Ion<br>Power Supply: 100-240V AC, 50-60 Hz | Battery type: Lithium-Ion<br>Power Supply: 100-240V AC, 50-60 Hz | # Table 1 Comparison of the Nihon Kohden SVM-7200 Series Vital Signs Monitor to its Predicate {7}------------------------------------------------ These differences between the subject device and predicate are describe below: 1. NIBP Measurement Ranges: The SVM-7200 has a higher end cut-off for systolic, diastolic and mean arterial pressure ranges for adults, pediatrics, and neonates as compared to the predicate. The subject device complies with the NIBP standard IEC 80601-2-30. 2. SpO2 Monitoring: The SVM-7200 offers additional SpO2 probe options as compared to the predicate which only offers the Masimo SpO2 probe. The SVM-7200 can be used with its own Nihon Kohden SpO2 and Nellcor SpO2 pulse oximeter probes. All three SpO2 probe options were tested with the subject device which complies with the SpO2 standard IEC 80601-2-61. 3. Operating Conditions: The SVM-7200 has a lower minimum operating temperature of 5°C as compared to 10°C of the predicate and reference devices. Also, the subject device has a lower maximum operating humidity of 85%, while the predicate and the reference device have a maximum humidity of 95%. This very minor difference should not affect the general functionality of the device and has no effect on safety or effectiveness. The subject device has been tested and complies to IEC 60601-1. 4. Storage Conditions: The SVM-7200 has a higher maximum storage temperature of 65°C, as compared to 50°C of the predicate. Also, the subject device has a higher maximum storage humidity of 95% while the predicate has a maximum humidity of 90%. This very minor difference should not affect the general functionality of the device. The subject device has been tested and complies to IEC 60601-1. Since some of the features are not exactly the same between the subject device and the predicate, a reference device, the Nihon Kohden Bedside Monitor, BSM-6000 series (K080342) is utilized to provide technical information to help address the safety and effectiveness of the different characteristics. The methods used to test the SVM-7200 series Vital Signs Monitor are according to the same standards as the cleared reference device BSM-6000 and have been deemed acceptable. Also, the BSM-6000 series incorporates the NIBP module. SpO2 module and firmware of the same design as the SVM-7200 series which controls the operation of NIBP (including measurement ranges) and SpO2 monitoring. Additionally, the storage conditions of the BSM-6000 series bedside monitor are the same as for the SVM-7200 series Vital Signs Monitor and the method used to test the maximum storage temperature and humidity is the same. ## PERFORMANCE TESTING Performance testing for the Nihon Kohden SVM-7200 series Vital Signs Monitor includes software verification and validation test which encompassed software unit testing, integration level testing, and system level testing. A system test was also performed per the software requirements specification. A summative usability validation has been conducted with the subject device in a simulated environment. Testing to compliance standards for electrical and electromagnetic safety was also performed. {8}------------------------------------------------ Traceability has been documented between all system specifications to validation test results. Table 2 lists the performance testing to compliance standards for the VSM-7200 series Vital Signs Monitor. | Performance<br>Characteristics | Standard Number | Standards Title | |--------------------------------|---------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | General | IEC 60601-1:2005 +<br>CORR.1:2006 + CORR.<br>2:2007 + A1:2012 (with<br>CAN/CSA C22.2 No.60601-<br>1:14) | Medical electrical equipment - Part 1: General<br>requirements for basic safety and essential<br>performance | | EMC | IEC 60601-1-2:2014 | Medical Electrical Equipment - Part 1-2: General<br>Requirements for Basic Safety and Essential<br>Performance - Collateral Standard: Electromagnetic<br>Compatibility - Requirements and Tests | | Usability | IEC 60601-1-6:2010 + Amd<br>1:2013 | Medical Electrical Equipment - Part 1-6: General<br>Requirements for Basic Safety and Essential<br>Performance - Collateral Standard: Usability | | | IEC 62366:2007 +<br>Amendment 1:2014 | Medical devices -- Application of usability<br>engineering to medical devices | | Alarms | IEC 60601-1-8:2006 &<br>A1:2012 | Medical electrical equipment - Part 1-8: General<br>requirements for basic safety and essential<br>performance - collateral standard: General<br>requirements, tests and guidance for alarm systems<br>in medical electrical equipment and medical<br>electrical systems | | Patient<br>Monitoring | IEC 60601-2-49:2011 | Medical electrical equipment - Part 2-49: Particular<br>requirements for the basic safety and essential<br>performance of multifunction patient monitoring<br>equipment | | NIBP | IEC 80601-2-<br>30:2009+A1:2013 | Medical electrical equipment - Part 2-30: Particular<br>requirements for the basic safety and essential<br>performance of automated non-invasive<br>sphygmomanometers | | Temp | ISO 80601-2-56:2009 | Medical Electrical Equipment - Part 2-56: Particular<br>Requirements for the Basic Safety and Essential<br>Performance of Clinical Thermometers for Body<br>Temperature Measurement | | SpO2 | ISO 80601-2-61:2011 | Medical electrical equipment - Part 2-61: Particular<br>requirements for the basic safety and essential<br>performance of pulse oximeter equipment | | Software | IEC 62304:2006 +<br>Amd1:2015 | Medical Device Software - Software Life-cycle<br>Processes | | Wireless and Co-<br>Existence | AAMI TIR69: 2017 | Technical Information Report Risk management of<br>radio-frequency wireless coexistence for medical<br>devices and systems. | | Performance<br>Characteristics | Standard Number | Standards Title | | Wireless and Co-<br>Existence | ANSI IEEE C63.27-2017 | American National Standard for Evaluation of<br>Wireless Coexistence | | | ANSI IEEE C63.4-2003 | American National Standard for Methods of<br>Measurement of Radio-Noise Emissions from Low<br>Voltage Electrical and Electronic Equipment in the<br>Range of 9 kHz to 40 GHz. | ## Table 2 Performance Testing to Standards {9}------------------------------------------------ # CLINICAL ACCURACY VALIDATION The Nihon Kohden SVM-7200 series Vital Signs Monitor incorporates clinical subsystems from Masimo, Nellcor and Nihon Kohden for SpO2 monitoring, from Covidien and Exergen for temperature measurement, and from Nihon Kohden for NIBP monitoring. New clinical accuracy validation testing was not necessary as these subsystems along with their accessories have been previously validated and cleared. This 510(k) leverages the previous clinical accuracy data from the predicates, as shown in Table 3, for all of the clinical functionalities in the subject device. {10}------------------------------------------------ | Patient<br>Monitoring<br>Subsystem | Data Collection Method | | Subsystem Cleared in 510(k) | | SVM7200 Model | | | |-------------------------------------------------------------------------------|-----------------------------------------|---------------------------------------|------------------------------------------|------------------------------------------------------------------------------------------------|---------------|--------------|--------------| | | Method | Component | 510(k) | Device Name<br>Manufacturer | SVM-<br>7230 | SVM-<br>7250 | SVM-<br>7260 | | Oxygen<br>Saturation<br>(SpO2)<br>Masimo | Masimo | Board,<br>Algorithm | K053269<br>K080342 | Masimo Set Rad-8 Pulse Oximeter<br>Masimo<br>BSM-6000<br>Nihon Kohden | X | | | | | | Sensor cable<br>(connection<br>cord) | K080342<br>K151080 | BSM-6000 (for JL-632P)<br>Nihon Kohden<br>CSM-1901(for JL-631P)<br>Nihon Kohden | X | | | | | | Probes | K040214<br>K060143<br>K992340 | SpO2 probe<br>Masimo | X | | | | Oxygen<br>Saturation<br>(SpO2)<br>Nellcor | Nellcor | Board,<br>Algorithm | K060576<br>K080342 | N-600X<br>Nellcor<br>BSM-6000<br>Nihon Kohden | | X | | | | | Sensor cable<br>(connection<br>cord) | K151080 | CSM-1901<br>Nihon Kohden | | X | | | Patient<br>Monitoring<br>Subsystem | Data Collection Method | | Subsystem Cleared in 510(k) | | SVM7200 Model | | | | | Method | Component | 510(k) | Device Name<br>Manufacturer | SVM-<br>7230 | SVM-<br>7250 | SVM-<br>7260 | | Oxygen<br>Saturation<br>(SpO2)<br>Nihon Kohden<br>Nihon Kohden | | Probes | K052186<br>K012891 | SpO2 probe<br>Nellcor | | X | | | | Nihon<br>Kohden | Board,<br>Algorithm | K080342 | BSM-6000 Nihon Kohden | | | X | | | | Sensor cables<br>(connection<br>cord) | K082785 | BSM-9100<br>Nihon Kohden | | | X | | | | | K163459 | GZ-140P<br>Nihon Kohden | | | X | | | | Finger probes | K043517 | ZS-940P<br>Nihon Kohden | | | X | | | | Multisite<br>probes | K043517 | ZS-940P<br>Nihon Kohden | | | X | | | | Disposable<br>probes | K120888 | PSG-1100<br>Nihon Kohden | | | X | | | | | K151080 | CSM-1901<br>Nihon Kohden | | | X | | K163459 | | | GZ-140P<br>Nihon Kohden | | | X | | | Patient<br>Monitoring<br>Subsystem | Data Collection Method | | Subsystem Cleared in 510(k) | | SVM7200 Model | | | | | Method | Component | 510(k) | Device Name<br>Manufacturer | SVM-<br>7230 | SVM-<br>7250 | SVM-<br>7260 | | Non-invasive<br>Blood Pressure<br>monitoring<br>(NIBP)<br>(inflation<br>mode) | Nihon<br>Kohden<br>iNIBP<br>(inflation) | Board,<br>Algorithm | K163459 | GZ-140P<br>Nihon Kohden | X | X | X | | | | Sensor cables<br>(air hoses) | K082785 | BSM-9100<br>Nihon Kohden | X | X | X | | | | Cuffs -<br>Reusable and<br>disposable | K163459 | GZ-140P<br>Nihon Kohden | X | X | X | | Non-invasive<br>Blood Pressure<br>monitoring<br>(NIBP)<br>(deflation<br>mode) | Nihon<br>Kohden<br>NIBP<br>(deflation) | Board,<br>Algorithm | K914092<br>K011918<br>K032749<br>K080342 | BSM-2101<br>BSM-2302<br>OPV-1510<br>BSM-6100<br>Nihon Kohden | X | X | X | | | | Sensor cables<br>(air hoses) | K151080 | CSM-1901<br>Nihon Kohden | X | X | X | | | | | K082785 | BSM-9100<br>Nihon Kohden | X | X | X | | | | Cuffs -<br>Reusable and<br>disposable | K163459 | GZ-140P<br>Nihon Kohden | X | X | X | | | Data Collection Method | | Subsystem Cleared in 510(k) | | SVM7200 Model | | | | Patient<br>Monitoring<br>Subsystem | Method | Component | 510(k) | Device Name<br>Manufacturer | SVM-<br>7230 | SVM-<br>7250 | SVM-<br>7260 | | Body<br>Temperature<br>(TEMP) | Covidien | Board.<br>algorithm | K003313 | FILAC FAS TEMP<br>Covidien | X | X | X | | | | Thermometer<br>probe | K003313 | FILAC FAS TEMP<br>Covidien | X | X | X | | | | Accessories | K003313 | FILAC FAS TEMP<br>Covidien | X | X | X | | Body<br>Temperature<br>(TEMP) | Exergen | Thermometer | K011291<br>K171751 | Temporal Scanner<br>Exergen<br>SmartLinx Vital Plus Patient Monitoring<br>Capsule Technologies | X | X | X | # Table 3 SVM-7200 Series Clinical Subsystems in SVM-7200 Series with Corresponding Subsystems in Predicates {11}------------------------------------------------ {12}------------------------------------------------ {13}------------------------------------------------ {14}------------------------------------------------ ## CONCLUSION Based on a review of indications for use, technological characteristics, safety and performance testing, the Nihon Kohden SVM-7200 series Vital Signs Monitor is as safe and effective as the SmartLinx Vitals Plus Patient Monitoring System for the intended use described above. Furthermore, the minor differences do not raise new concerns of safety and effectiveness. Therefore, the data provided shows that the subject device is substantially equivalent to the predicate.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...